Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rx Rebates To Foreign Governments Could Blunt Reimportation

Executive Summary

Drug manufacturers' recent pricing actions overseas may signal a new strategy to counter proposals for reimporting drugs into the U.S., American Enterprise Institute fellow Scott Gottlieb, MD, suggested Nov. 9

You may also be interested in...

GOP Victory Won’t End Rx Import Debate: New Senators Want Open Borders

Seven of the nine new Senators who will join the chamber in January have professed their support for importing prescription drugs into the U.S

CMS’ Gottlieb returns to AEI

Centers for Medicare & Medicaid Services Senior Advisor for Medical Technology Scott Gottlieb, MD, is leaving the agency for the American Enterprise Institute. Gottlieb is returning to AEI to serve as a fellow after serving as an advisor to Mark McClellan both at FDA, where McClellan was commissioner from November 2002 to February 2004, and CMS, where McClellan is administrator (1"The Pink Sheet" May 10, 2004, p. 32)...

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts